Jean-Marie Vogel

Jean-Marie Vogel General Information

Biography

Mr. Jean-Marie Vogel served as Senior Partner at Mérieux Développement. He Co-Founded Pluromed, Inc. in 2003, a breakthrough vascular and cardiovascular medical device company, and served as its CEO until its acquisition by Sanofi Genzyme in 2012. From 2002 to 2005 and in parallel to management of Pluromed, he served as CEO of Cryoma Laboratories, an autologous tumor cell bank to help cancer patients, which was sold to Cancer Therapeutics in 2005. In 1999, he founded BioSphere Medical, a leading interventional oncology company and the world leader in embolotherapy, where he served as its Chairman until 2002. The company was later acquired by Merit Medical. From 1994 to 1999, he served as the CEO of BioSepra, Inc., a leader in process chromatography for monoclonal antibodies and gene therapy, after having co-managed its public spin-off from Sepracor, Inc. BioSepra was sold to Life Technologies in 1999. Prior assignments included President of Cuno Europe, based in Paris, France and various commercial leadership positions for Millipore Corporation in Europe, Africa, Asia and the United States. He graduated in Applied Mathematics from Ecole Centrale de Paris, one of the leading engineering schools in France.